Home
Emcure Pharmaceuticals Ltd 52 Week Low

Emcure Pharmaceuticals Ltd
NSE: EMCURE
YEARLOW
Key Highlights
- The 52 Week Low of Emcure Pharmaceuticals Ltd is ₹ 911.75 as of 02 Apr 25 .
Company Fundamentals for Emcure Pharmaceuticals Ltd
Market Price of Emcure Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
02 Apr 2025 | 1054.9 |
01 Apr 2025 | 1076.55 |
28 Mar 2025 | 1072.8 |
27 Mar 2025 | 1046.15 |
26 Mar 2025 | 1024.65 |
25 Mar 2025 | 1006.45 |
24 Mar 2025 | 1061.75 |
21 Mar 2025 | 1029 |
20 Mar 2025 | 1001.05 |
19 Mar 2025 | 932.45 |
Asset Value vs Market Value of Emcure Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Emcure Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Emcure Pharmaceuticals Ltd
Historical Net Profit of Emcure Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd News Hub
Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs
Read more
13 Aug 24
Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank
Read more
13 Aug 24
Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter
Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Emcure Pharmaceuticals to declare Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202
Read more
10 Aug 24